Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This was an interesting move on Alexza's part. I'll be curious to see how the market reacts. Generally, the market has hated anything "interesting" the company has done. Hopefully more information will be forth coming at Thursday's 3rd Quarter meeting.
I think the "allow the use of the product in the outpatient setting" is key.
Not sure what the new "strategy" will be but in the past this has never led to increased shareholder value (very long time holder here).
This is odd.....even for Alxa. What's with the sudden ramp up in volume at ~15:00 (3:00 p.m.)? I mean a few thousand shares till then and suddenly ~80K shares....Very unusual. And it's staying in the green...Curiouser and curiouser.
Worst performing stock I've held up to now. Nothing but decent news and it continues the long spiral down.....Not to mention the impact of the current biotech sell-off. At these prices I've thrown in some shares in my 401K versus my "mad money" fund where I've taken the majority of my losses. The odd thing is the average brokerage recommendation (ABR)is buy...but the reports say sell. I guess on the bright side; no dilution, restarting pipeline, some TEVA progress (as much as I can tell), shopping for partners for non-allocated territories (Asia, etc.)should show some results in the next 60-90 days (I'm guessing here). I've held this too long now and since I don't need the funds for anything else I might as well hang in for a bit longer.
Taking a beating here. Looks like just about everyone else is too. Picked up a few more shares at $4.03. About time (past time) for a decent PR here....Of course ALXA stock always goes down on PR (good or bad).
Very kind of you.
I'm anticipating it's the partnership deal....But, this being Alexza.......dilution is always a possibility.
Yes it has been a quiet run up, along with a quite (soft) launch by TEVA. Nothing spectacular on any given day just "below the radar" activity. I'm cautiously encouraged.
No news is good news for ALXA? Haven't been back to this board in a while. Very little news (good or bad) recently. I think this quiet (soft) launch and institutional buying is encouraging. Two (2) weeks (06 March) till the year end reporting so, there may be a bit of a run up. I believe the ALXA "International" leadership has been in place for long enough we may begin to see some of the other areas (Japan, China, Canada...etc) make deals (probably another 3 months out).
Anybody else make money on PRAN (I got in at ~$2.00)? Heck of dueling "Experts" battle going on there. Alzheimer's results due our in March for them....Could be a very good month for me (about time).
Full disclosure: I'm in ALXA at ~$6.50.....and I've been VERY patient with this stock.
Teva Adasuve launch soon? While many are predicting/anticipating launch in January, I'm not sure this is very high probability given the late (January) hires by TEVA. Probably need to give the new hires a bit of time to get on-board. February? Maybe....March more likely. Anyway, only 11 more days in January till we find out. Let's just say I haven't had too many pleasant (ahead of schedule) surprises with this stock.
~$157 price for Adasuve? Not sure if that's good or bad but considering I paid $186 for a shingles vaccine Friday (not covered by my insurance) probably not totally out of whack.
I'm actually more curious about when we'll hear about deals in Asia and Canada (etc). This could provide a nice bump in stock price. This may have to wait till after the Adasuve launch in the US......It's what I'd do to (hopefully) get a better deal; bootstrapping off the TEAV launch.
Haven't been back to this board in a while...Hope you're all doing well.
The funniest (most interesting?) comment was King didn't understand why the stock price wasn't higher either...
Transcript of Piper meeting:
http://seekingalpha.com/article/1875291-alexza-pharmaceuticals-ceo-presents-at-piper-jaffray-healthcare-conference-transcript?source=yahoo
Some nice anecdotal (meaning take it with a grain of salt) stories from Germany. Stock price still on hold....
Teva's CEO (Levin) resigns/is fired. An Alexza surprise but, this one was not exactly self inflicted. However, being Alexza's US partner....we'll probably see some collateral damage to the Alexza stock price over the next weeks....purely a knee jerk reaction I'd think. Never a dull moment for this stock.
Leveling around the 5.10+/- for the past month. Certainly better than the sub-5.00 previously. Very quiet on the PR front. Next earnings results due 04 November (14 working, 20 calendar days). Nice opportunity in the next couple of weeks for announcement of another deal in the as yet unallocated countries/regions. Don't really expect much from the German sales release.
Or, there might be some unexpected "Alexza Weirdness".....It's been known to happen. But, I think the company has matured and gained some financial stability to put it a bit past that.
Inching up with the expected "Alexza weirdness" going on. I'm moderately encouraged at this point. I've had to hold this much, much longer that I originally expected (2 years) but, barring any surprises will as a minimum break even within the next 3-6 months. By way of full disclosure I'm averaged in at $6.60.
Relatively small insider buys but....with this stock, who knows...it could have been the trigger. Insider buying is however, unusual for this management. Whatever the reason, it's nice to see it going the other way (up) for a change.
Good movement...Wonder what set this off?....and is it a trend and not a one-off indicator?...
Roundup:
Is it me or, does this German Adasuve site look pretty poor?
http://www.adasuve.de
And to add insult to injury....Edison picking up coverage at $6.77. I'll barely recover my loses at that level...
On the good news side; Jason Napodano gives it an "Eh, I don't think Adasuve is going to do all that well but downside seems limited here with good support. Might be worth a trade."
High praise indeed from Jason on this stock...
Some interesting trading going on here. Wish I had gotten in at these levels.....versus the $6.50 I'm at. However I'm now much more confident the stock will return to or surpass these levels in the near future (too chicken to actually predict when).....Granted there may be some ALXA weirdness along the way.
Nice to see the CEO purchasing on the open market. Given this stock's erratic behavior in the past I'll withhold judgment on the implications. But, I'm long....very long..so I'm cautiously optimistic.
Interesting...Someone taking an interest: This guy is with Edison Investment Research,
http://wallstreetsectorselector.com/2013/07/the-growing-appetite-for-biotech-pooya-hemami/#
I added ~1000 shares at a ~$4.40 average. I'll check out the others you mention.
If this drops again today I may pick up a few more shares. Despite the continued ALXA weirdness I think they may have turned the corner and anything below $4.50 (0.45 pre-reverse split) may turn out to be a bargain. But....don't forget, I've been wrong (very wrong) on ALXA before and there are plenty of others with exactly the opposite opinion. Either way....enjoy the ALXA weird ride!
What's your take on a timeframe for $6.00? As for me, at this point I'm afraid to guess with this stock. Any impacts based on the Azimuth purchase of 1,437,481 shares (at $4.48)?
Lots of confusion...over on Yahoo and other message boards regarding this stock. I could have told them, this is one confusing stock....
I couldn't take the loss and stayed in. Averaged down to $6.50 (after buying in the $4-$4.50 range). Hopefully will make that back and more (considering all the time and angst involved). In any case, at these levels and my average cost I'd take a lot less of a hit (which was huge at one point). Have you looked at PRAN? I'm looking at it for a long term Alzheimers / Dementia / Huntingtons cure/reversal play. Science looks pretty good (those Aussies tend to do their homework). It's been stuck in the $2.20 range for a while till results of their Huntingtons trail comes out. Might be a good buy......or not.
Are you still in this? I thought you dropped out? I'm still hanging around (with the same losses)....This stock continues to be one strange trip.
Lack of pumpers here (even the more obvious ones)is probably a sign of something.... Of what I'm not sure. Capitulation?
Alexza management is 1/3 of the way through 2nd quarter. Probably the latest they can announce whatever strategy they decide to go with is the end of 2nd quarter. This would give them a little reaction time (90 days)to emplace/train any sales force prior to their actual Q3 launch (Management's announced launch date). They are really playing it close timing wise, whatever decision they make.
Per their last Stockholders meeting they intend to pursue "the best commercial arrangement for ADASUVE in which we will build near- and long-term value for Alexza and its stockholders through the commercial success of this product."
Bottom Line: Next 60 days should reveal the Alexza strategy.... for better or worse.
Nothing posted here since 10 April. Wow. Usually (based on past history) no news from Alexza is not a good thing. They have scheduled a 09 May 1st Quarter results meeting. Obviously that can't be good news unless they announce a deal with some one. There doesn't seem to be any discussion on any of the other message boards except predictions of dilution. Without any deal that has to happen sooner rather than later but some of that might be priced in..maybe? Slow decline in share price over the last weeks with low volume.
No announcement of what (if any) strategy they've selected (which everyone knows was supposed to occur 1st quarter).
I'm afraid I'm going to be singing those Alexza blues.....again.
After hours 222186 volume at $4.3184 (nice for them). An additional sombody getting interested.
Looks like it's making back some of yesterdays losses....Darn it, there goes my buying opportunity. Maybe the afternoon dip will kick in.
This is one case where I'm glad the price got hammered. If the beating continues this morning (after the usual initial upswing) I'm going to pick some more up.
I think Tom King did a reasonable (good?) job yesterday and I was very glad to see him recognize Alexza personnel several times. Management had never done this before. With the layoffs and his (and the executives) taking in large (huge?) bonuses for FDA/EU approval, unless he treats the employees with the respect they deserve he could have found himself in a different sort of trouble. I think this recognition may signal a turn-around for Management.
Despite the fact there was no partnership announcement I'm glad Alexza isn't rushing into this, has very good advisors and is taking the time to work out the best deal (maybe not for stockholders). They are in a very good position and they need to find the right partner for moving ahead. Go ahead and take your time....I've been waiting this long.....
Also, thanks go out to the guy from WBB securities for asking the right questions.
I'll probably pick up some small additions around the $4.10 - $4.20 region if there is a graceful degradation in share price. If it drops even lower quickly tomorrow I'll jump on it with both feet.
Per conference call:
No Q1 partnership announcement.
No firm date for partnership announcement (other than prior to launch).
No decision on which of the two potential strategy options for partnership will be selected.
Will not try and go it alone.
Multiple negotiations on-going.
Bottom Line: Awaiting partnership deal somewhere April-June(+?)
03/18 Roth Capital briefing (chart 33): "Goal is to finalize commercial strategy by end of Q1 2013". Note this statement does not say that the strategy will be executed but rather seems to indicate that one of the two strategies (chart 33); 1) Traditional Partnership or 2) CSO and royalty company, will be selected (amoung multiple potential partners). So, those of us looking for a "deal" in the next few days will possibly see a "strategy selection" instead. This argument is supported by the recent addition of Peter W. Schineller as Senior Vice President and Chief Commercial Officer who would need time to react. Another price drop is likely in store if this occurs however, this would give management another quarter (+) to execute the commercial strategy before launch in Q3.
Reference:
http://wsw.com/webcast/roth27/alxa/
Pretty quiet on the ALXA front.....These eerie quiet phases have never boded well for ALXA. With the yearly (2012) results on the 26th I'd think they make any partnership deals public before then to offset all that spending.....or not...it is ALXA after all and surprises are the norm.
Interesting "Thomas King, the much reviled CEO of Alexza" comment in this article. Otherwise this is the most postive SA article on Alexza I've seen to date. I assume we'll just wait for the other side to chime in shortly.
Here's the link:
http://seekingalpha.com/article/1250811-why-alexza-pharmaceuticals-ran-10-in-5-minutes?source=yahoo
09:45 and not a single share traded? Is it me or is this just too weird....even for Alxa...
Does all this investor conference participation this mean they DON'T have a potential partner? Yikes....again...
http://phx.corporate-ir.net/phoenix.zhtml?c=196151&p=irol-newsArticle&ID=1788736&highlight=
Past: FDA approval..down...EU approval...down..
Future: Partnership....down?....Dilution.....Up? Only Alxa...
Well...if I haven't capitulated by now I guess it's worth seeing Partnership moves(~47 days).